Ask most clinical teams how they dose peptides, and you'll get a confident answer measured in units.
Ask them what those units actually translate to in milligrams, and the room often goes quiet.
That gap — between dosing by volume and dosing by drug — is one of the most overlooked vulnerabilities in clinical peptide programs. It works fine when everything stays the same. It falls apart the moment anything shifts.
In a recent breakdown, Heather McKerrow, PA-C explains why the difference between units and milligrams matters more than most clinics realize, and why thinking in milligrams is one of the fastest ways to level up clinical confidence, consult quality, and patient outcomes.
The Real Difference Between Units and Milligrams
The distinction sounds technical, but it isn't.
Units measure volume. They tell you how much liquid is being drawn into the syringe.
Milligrams measure the actual dose. They tell you how much of the peptide the patient is receiving.
Those are not the same thing.
Two patients can receive the same number of units and end up with completely different doses depending on the concentration of the peptide in the vial. Two protocols can read identically on paper and deliver different clinical outcomes for the same reason.
When a clinic dose in units without understanding the milligram equivalent, the protocol is only as consistent as the assumptions underneath it.
Why Units Alone Lead to Dosing Mistakes
The unit-only approach works in a controlled environment. Same vial, same concentration, same reconstitution practice, same patient population. As long as nothing changes, the math holds.
The problem is that things change constantly:
- Vial sizes shift between suppliers or batches
- Concentrations vary depending on how the peptide is reconstituted
- New team members reconstitute differently than the team they're replacing
- A patient transitions to a different vial size and the units no longer mean the same dose
Each of these moments is where dosing errors enter the program — quietly, often without anyone realizing it happened.
Did You Know?
A patient receiving the "same dose" of a peptide at two different clinics may actually be receiving very different amounts of drug, depending on how each clinic reconstitutes the vial. Units don't travel between protocols. Milligrams do.
How Concentration Changes Everything
Concentration is the variable most clinics underestimate.
The amount of bacteriostatic water used to reconstitute a vial directly determines how many milligrams are present in each unit drawn into the syringe. Change the volume of water, and the dose per unit changes — even though the unit count looks the same.
This is why two clinics following "the same protocol" can produce noticeably different patient results. They aren't actually following the same protocol. They're following the same volume.
Once a clinical team understands this, the entire approach to dosing shifts. The vial isn't a fixed unit of medication. It's a dilution that depends on how it's prepared.
The Most Common Reason Patients "Stop Responding"
One of the most frequent calls clinic owners receive is some version of: "This was working great, and now it's not."
The clinical instinct is to look at the patient. Tolerance, downregulation, lifestyle changes, compliance issues — all reasonable places to start.
But often, the variable that actually changed wasn't the patient. It was the dose.
A new vial size. A different reconstitution. A subtle shift in concentration that no one flagged because the unit count stayed the same. The patient is still drawing 20 units — but 20 units now means something different than it did three months ago.
Clinics that think in milligrams catch this immediately. Clinics that think in units rarely do.
Standardizing Dosing Across Your Team
The fix isn't complicated, but it requires intention.
Strong peptide programs build their dosing standards around the milligram, not the unit. The unit is a useful tool for patient education and at-home administration — but it isn't the foundation of the protocol.
That means:
- Every protocol is documented in milligrams, with units calculated from there
- Reconstitution practices are standardized across the team so concentration doesn't drift
- Vial size changes trigger a recalculation, not a continuation of the same unit count
- Patient instructions reflect the actual dose, not just the volume drawn
- The clinical team can articulate what's being given and why
This is what consistency actually looks like. It's not memorizing the same number across patients. It's anchoring every protocol to a unit of measurement that doesn't shift when external variables do.
Reality Check
If your team can tell you the unit count but not the milligram dose, your protocols aren't as standardized as they appear. They're standardized to a vial — not to a patient.
Why Thinking in Milligrams Changes Clinical Confidence
The shift from units to milligrams isn't just a technical upgrade. It's a clinical one.
When practitioners understand the dose at the milligram level, every consult changes. They can explain what they're giving with precision. They can adjust intelligently when patients aren't responding. They can move between vial sizes, suppliers, and concentrations without losing the integrity of the protocol.
That confidence translates directly to the patient experience. Patients can tell the difference between a clinician who is reading instructions and a clinician who actually understands the medicine they're prescribing.
Programs built on milligram-level thinking sound different in the consult room. And patients respond to that difference.
Where This Shows Up in Underperforming Programs
The clinics that struggle most with peptide programs share a common pattern:
- Protocols are written in units only
- Reconstitution varies depending on who's working that day
- Patient questions about dosing are deflected or oversimplified
- Switching vial sizes creates confusion across the team
- Inconsistent results get attributed to the patient rather than the protocol
None of these are unfixable. All of them point back to the same root issue: the program never made the shift from volume to dose.
What This Means for Your Practice
If your team can dose in units but stumbles when asked about milligrams…
If patient results feel inconsistent without a clear clinical explanation…
If switching vials, suppliers, or concentrations creates uncertainty no one wants to address…
That's not a knowledge gap. It's a protocol gap.
And it's one of the most common — and most fixable — vulnerabilities in clinical peptide programs today.
👉 Ready to Build Protocols Your Team Actually Understands?
Explore the frameworks, dosing tools, and clinical resources Aura provides to help wellness clinics build peptide programs grounded in precision, consistency, and clinical confidence.